{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:35:35Z","timestamp":1777286135825,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.antiviral.2016.08.019","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T14:38:09Z","timestamp":1472135889000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus"],"prefix":"10.1016","volume":"134","author":[{"given":"Amrita","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer S.","family":"Bhagyawant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manmohan","family":"Parida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paban Kumar","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.08.019_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2015.06.017","article-title":"Towards antivirals against chikungunya virus","volume":"121","author":"Abdelnabi","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.019_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jviromet.2013.07.004","article-title":"Application of real-time RT-PCR in vector surveillance and assessment of replication kinetics of an emerging novel ECSA genotype of Chikungunya virus in Aedes aegypti","volume":"193","author":"Agarwal","year":"2013","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2016.08.019_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.antiviral.2013.08.010","article-title":"Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus","volume":"100","author":"Bhomia","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.019_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pharmtox-010715-103633","article-title":"RNA interference (RNAi)-based therapeutics: delivering on the promise?","volume":"56","author":"Bobbin","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.antiviral.2016.08.019_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2008.231","article-title":"Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in\u00a0vitro and in\u00a0vivo","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2016.08.019_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2003.09.005","article-title":"In\u00a0vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-\u03b1 and ribavirin combination","volume":"61","author":"Briolant","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.019_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201100054","article-title":"Current progress of siRNA\/shRNA therapeutics in clinical trials","volume":"6","author":"Burnett","year":"2011","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.antiviral.2016.08.019_bib8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.08.019_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0028-3886.51289","article-title":"Neurological complications of chikungunya virus infection","volume":"57","author":"Chandak","year":"2009","journal-title":"Neurol. Ind."},{"key":"10.1016\/j.antiviral.2016.08.019_bib10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbrc.2008.09.040","article-title":"RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells","volume":"376","author":"Dash","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.08.019_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2016.08.019_bib12","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1073\/pnas.1322937111","article-title":"Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates","volume":"111","author":"Dong","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2016.08.019_bib13","doi-asserted-by":"crossref","first-page":"e1446","DOI":"10.1371\/journal.pntd.0001446","article-title":"Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia","volume":"6","author":"Dupuis-Maguiraga","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.08.019_bib14","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/art.21886","article-title":"Gene therapy for arthritis: what next?","volume":"54","author":"Evans","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.antiviral.2016.08.019_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.cr.7290248","article-title":"RNAi, a new therapeutic strategy against viral infection","volume":"14","author":"Fischer","year":"2004","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2016.08.019_bib16","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1073\/pnas.0402486101","article-title":"Inhibition of influenza virus production in virus-infected mice by RNA interference","volume":"101","author":"Ge","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.019_bib17","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1371\/journal.pmed.0050060","article-title":"Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion","volume":"5","author":"Gerardin","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2016.08.019_bib18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1369","article-title":"RNA interference against viruses: strike and counterstrike","volume":"25","author":"Haasnoot","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2016.08.019_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2012.10.008","article-title":"An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAs","volume":"97","author":"Ibrisimovic","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.019_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2009.07.012","article-title":"Inhibition of rabies virus replication by multiple artificial microRNAs","volume":"84","author":"Israsena","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.019_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature00896","article-title":"Modulation of HIV-1 replication by RNA interference","volume":"418","author":"Jacque","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.08.019_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2010.10.009","article-title":"Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells","volume":"89","author":"Khan","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.019_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2006","article-title":"Strategies for silencing human disease using RNA interference","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2016.08.019_bib24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.antiviral.2016.08.019_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046396","article-title":"Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced chikungunya virus replication","volume":"7","author":"Lam","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2016.08.019_bib26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1280","article-title":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque","volume":"11","author":"Li","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.08.019_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1472-6750-12-42","article-title":"Optimization and comparison of knockdown efficacy between polymerase II expressed shRNA and artificial miRNA targeting luciferase and Apolipoprotein B100","volume":"12","author":"Maczuga","year":"2012","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.antiviral.2016.08.019_bib28","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.019_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002405","article-title":"Administration of E2 and NS1 siRNAs Inhibit Chikungunya Virus Replication In\u00a0Vitro and Protects Mice Infected with the Virus","volume":"7","author":"Parashar","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2016.08.019_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2966","article-title":"RNA interference in the clinic: challenges and future directions","volume":"11","author":"Pecot","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.antiviral.2016.08.019_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.070136-0","article-title":"Risks to the Americas associated with the continued expansion of chikungunya virus","volume":"96","author":"Powers","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.019_bib32","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","article-title":"Neutral red uptake assay for the estimation of cell viability\/cytotoxicity","volume":"3","author":"Repetto","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2016.08.019_bib33","doi-asserted-by":"crossref","first-page":"e0126360","DOI":"10.1371\/journal.pone.0126360","article-title":"A\u00a0Combination of Doxycycline and Ribavirin Alleviated Chikungunya Infection","volume":"10","author":"Rothan","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2016.08.019_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11908-011-0180-1","article-title":"Chikungunya virus infection","volume":"13","author":"Simon","year":"2011","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.antiviral.2016.08.019_bib35","series-title":"Gene Therapy for Autoimmune and Inflammatory Diseases","first-page":"181","article-title":"Delivery and application of plasmid DNA in arthritis gene therapy","author":"Subang","year":"2010"},{"key":"10.1016\/j.antiviral.2016.08.019_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature14442","article-title":"Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates","volume":"521","author":"Thi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.08.019_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.antiviral.2013.06.009","article-title":"Chikungunya fever: Epidemiology, clinical syndrome,pathogenesis and therapy","volume":"99","author":"Thiberville","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.019_bib38","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1073\/pnas.0402630101","article-title":"Protection against lethal influenza virus challenge by RNA interference in\u00a0vivo","volume":"101","author":"Tompkins","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.019_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/161794","article-title":"Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives","volume":"2014","author":"Torrecilla","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.antiviral.2016.08.019_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tibtech.2006.02.006","article-title":"The silent treatment: RNAi as a defense against virus infection in mammals","volume":"24","author":"van Rij","year":"2006","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.antiviral.2016.08.019_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2016.08.019_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/nat.2012.0405","article-title":"Inhibition of dengue virus 2 replication by artificial microRNAs targeting the conserved regions","volume":"23","author":"Xie","year":"2013","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/j.antiviral.2016.08.019_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-9-118","article-title":"Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct","volume":"9","author":"Zhang","year":"2012","journal-title":"Virol. J."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T19:36:29Z","timestamp":1568316989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216301528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":43,"alternative-id":["S0166354216301528"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.019","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}